Advaxis, Inc. Stock price OTC Bulletin Board
Equities
US0076241092
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
11:20am | North American Morning Briefing : Stocks Set for -2- | DJ |
Mar. 26 | Immunome, Inc. completed the acquisition of Assets from Ayala Pharmaceuticals, Inc.. | CI |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 29.84M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-04-22 |
Andres Gutiérrez
CTO | Chief Tech/Sci/R&D Officer | 63 | 18-04-22 |
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 13-07-15 |
Roni Appel
CEO | Chief Executive Officer | 57 | 04-10-31 |
Murray Goldberg
BRD | Director/Board Member | 79 | 23-01-18 |
1st Jan change | Capi. | |
---|---|---|
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |
- Stock
- Equities
- Stock Ayala Pharmaceuticals, Inc.
- Stock Advaxis, Inc. - OTC Bulletin Board